Webinar | AI in Life Science – the Quality and GxP perspectives

19 januari 2027
iStock-2150404554 (1)

The growing interest in AI/Machine learning across industries has naturally extended to the pharmaceutical industry and life science sectors. As companies increasingly start to use AI tools, understanding both the expectations of regulatory authorities, when and how these tools can be used in GxP settings and also learn smart usage where AI can create value for Life Science is becoming essential.

Join us for an insightful session on the intersection between AI, GxP and Quality Management with PharmaRelations’ experts: Kent Wiberg, Nordic Head of QA, Hossein Asgari, Head of QA Denmark, and Niels Buch Leander, Chief Digital Officer. 

Webinar Details 

📅 Date: Tuesday, January 19, 2027
🕓 Time: 15:00 – 15:45 CET (45 minutes)
📍 Location: Online

Register to the webinar

Agenda:

🔹When and how can we in LifeScience use AI/Machine learning in the process
of developing and manufacturing drugs?
🔹Content in regulations and guidelines, like EU GMP Annex 22
🔹When will the use of AI be considered as GxP activity?
🔹If the AI use is considered as GxP activity, what is the demands?
🔹How to get authorities approval for using AI tools in LifeScience?
🔹Smart examples when the use of AI actually can create value for LifeScience

The webinar is free to attend and open to all registered participants.

We look forward to a meaningful and engaging afternoon together!

25 november 2026
Science for breakfast_topp
Join us to learn how you can build a more digital workforce and be prepared to meet the evolving demands of the sector and lead your organization confidently into the future.

BREAKFAST MEETING IN SWEDEN| AI for Life Science Leaders

Cookies

This website use cookiesfor statistic and user experience.

Pharmarelations uses cookies to improve your user experience, to give basis for improvement and further development of the website and to be able to direct more relevant offers to you. Please read our personal data policy. If you agree to our use, select Allow All. If you want to change your choice afterwards, you will find that option at the bottom of the page.